3 ms·
As much as I understand your underlying horror that so much money is spent on promotion, I think you're missing a major point. Let's assume, for a moment, that
by mft_ 9y ago
As much as I understand your underlying horror that so much money is spent on promotion, I think you're missing a major point.
Let's assume, for a moment, that the people running these Pharma companies aren't stupid. We can therefore assume that they will mostly make sensible decisions on how to spend money. It therefore follows that a company calculates that by spending $X on promotion, they'll recoup $X+$Y, where Y is the additional revenue thanks to their promotion, over and above what they'd have made without promotion - i.e, their promotional spend is a worthwhile investment for them.
For each company individually, therefore, promotional spend can be reasonably assumed to generate greater revenue and profit, some of which will be used to fund research into new medicines.
Now, like you, I'd much rather live in a world where there was no promotional spend, and correspondingly lower drug prices... but that's not the current world. And pointing a finger --'but, marketing, sales reps'-- at promotion is not the full story.
- GeekyBear 9y agoYou seem to be ignoring the larger problem. Having the pharmaceutical industry arrange everything around the notion of "what is more profitable to us" leads them to ignore the notion of "what is best for patients with this condition". If unbiased studies show that their treatment is more effective and has less side effects than existing options, then it should become the usual treatment for that condition. Otherwise, no amount of advertising and promotional activity on their part makes sense when approached from the notion of what is best for patients. In the case of promoting Oxycontin to treat chronic pain, real harm has been done.